🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This is a phase II study designed to evaluate the toxicity and efficacy of ...
Status
Recruiting
Location
Universitaetsklinikum Aachen
Start Date
2025-10-31
Trial ID
NCT07197307
Treatments Being Tested
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
The purpose of this program is to provide investigational epcoritamab, an a...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05733650
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center - North Campus /ID# 227463
Start Date
2023-02-08
Trial ID
NCT05578976
Treatments Being Tested
This is a phase 2 study of Epcoritamab as a consolidation therapy for 2nd g...
Status
Recruiting
Location
University of Cincinnati
Start Date
2025-08-22
Trial ID
NCT07108998
Treatments Being Tested
The researchers are doing this study to find out whether the combination of...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-08-13
Trial ID
NCT07030699
Treatments Being Tested
This phase II trial compares epcoritamab to standard practice (observation)...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2024-01-31
Trial ID
NCT06238648
The purpose of this study is to evaluate the safety, tolerability, drug lev...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix
Start Date
2023-12-29
Trial ID
NCT06090539
Treatments Being Tested
This phase II trial tests the safety, best dose, and effectiveness of epcor...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-12-07
Trial ID
NCT07097363